SCHEMBL474508

SCHEMBL474508

CC(c1ccc(-c2ccc(C(=O)O)cc2Cl)cc1)C(O)(c1ccc2c(c1)n(C)c(=O)n2C)C(F)(F)F

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SRD5A2 P31213 2/20 0.41
TNKS2 Q9H2K2 1/20 0.38
ADH5 P11766 1/20 0.36
GCGR P47871 4/20 0.36
AKR1C3 P42330 6/20 0.36
AKR1C2 P52895 6/20 0.36
PPARD Q03181 1/20 0.35
ALDH1A1 P00352 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
GLA P06280 1/20 0.35
KDM4E B2RXH2 1/20 0.34
BRD4 O60885 1/20 0.34
BRPF1 P55201 1/20 0.34
HSD17B10 Q99714 1/20 0.34
PDK1 Q15118 1/20 0.34
PDK2 Q15119 1/20 0.34
PDK3 Q15120 1/20 0.34
PDK4 Q16654 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL474247 0.91 TNKS2 (0.39) SRD5A2TNKS2ADH5GCGRAKR1C3
SCHEMBL12163997 0.91 TNKS2 (0.39) SRD5A2TNKS2ADH5GCGRAKR1C3
SCHEMBL12163973 0.84 SMN1; SMN2 (0.37) ALDH1A1SMN1; SMN2GLAKDM4EBRD4
SCHEMBL474437 0.84 SMN1; SMN2 (0.37) ALDH1A1SMN1; SMN2GLAKDM4EBRD4
SCHEMBL474580 0.84 AKR1C3 (0.38) GCGRAKR1C3AKR1C2SMN1; SMN2BRD4
SCHEMBL474633 0.82 ALDH1A1 (0.41) AKR1C3AKR1C2ALDH1A1SMN1; SMN2GLA
SCHEMBL12163978 0.81 AKR1C3 (0.37) AKR1C3AKR1C2ALDH1A1SMN1; SMN2GLA
SCHEMBL474443 0.81 AKR1C3 (0.37) AKR1C3AKR1C2ALDH1A1SMN1; SMN2GLA
SCHEMBL15520758 0.78 BRD4 (0.38) SRD5A2GCGRAKR1C3AKR1C2ALDH1A1
SCHEMBL12163974 0.78 CMA1 (0.36) AKR1C2ALDH1A1SMN1; SMN2GLABRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2411365-A1 2,3-DIARYL- OR HETEROARYL-SUBSTITUTED 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS F. Hoffmann-La Roche AG (CH) 2012-02-01 EP disclosed
WO-2010108903-A1 2,3-DIARYL- OR HETEROARYL-SUBSTITUTED 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2010-09-30 WO disclosed